Nivolumab for previously treated gastric or gastro-oesophageal junction cancer [ID1118]
Discontinued
Reference number: GID-TA10151
Please note that following on from advice received from the company this appraisal has been rescheduled to align with latest regulatory expectations. Therefore, the committee discussion will now take place in July 2018.